A report on International Conference “Modern Treatment Strategies and Horizons in Hematology and Oncology” (June 30-July 1, 2017)

Abstract

A joint conference of clinicians from M.D. Anderson Medical Center (Houston, Texas, USA) and specialists from leading Russian hematological centers took place in St. Petersburg on June 30-July 1, 2017. A series of special sessions was dedicated to current issues of diagnostics and pathogenetic molecular classification in hemato-oncology, including chronic lymphocytic leukemia (CLL), acute leukemias (AL), aplastic anemias (AA), myelodysplastic syndrome (MDS), malignant lymphomas. Standard treatment schedules, as well as clinical effects of newly developed targeted drugs and combined therapeutic approaches were analyzed, with a focus on Hodgkin's disease, chronic lymphocytic and myeloid leukemias and multiple myeloma. Recent developments in AL treatment, especially, in acute myeloblastic leukemia, were also presented. Current position of hematopoietic stem cell transplantation as a curative treatment in some leukemia/lymphoma settings, opportunities for tumor immunotherapy (e.g., CART cells) and appropriate technologies were also discussed.